A new cow treatment that boosts the immune system in cows is a major step toward producing a calf with better immune systems and increased productivity, according to researchers.
The cow-to-human transplant project is the first of its kind in the world, and it involves using cow cells to grow new immune cells in human tissue and inject them into the patient.
The transplants are currently being used in China and Vietnam, and are scheduled to be expanded to other countries in the coming years.
In the future, the technology could be applied to other diseases that require the transplant of immune cells, said Michael R. Smith, a professor of medicine at the University of Texas Medical Branch at Galveston.
It could also be used to produce drugs or vaccines that would make animals more productive.
“This could be used in an emergency situation or to develop a vaccine or an immune system for a new disease,” Smith said.
“It could even be used for treating a type of cancer that is already very advanced.”
The researchers at the UTMB have been developing cow cells since 2010 and are now applying for a patent on the technology.
They hope to develop the technology for human use in the next two years.
The new method is being used by scientists in China to grow cells that could be implanted in a cow’s body to treat a variety of conditions, including heart disease, heart failure and lung cancer.
The cow cells are grown by an injection of antibodies called antibodies-a molecule that gives a person a strong response to a virus.
Researchers have been working for years to produce cow cells, including one in China that was used to develop drugs for cancer.
They developed a way to make the cow cells with antibodies-they could also make them with other antibodies.
But the antibodies didn’t work as well in a human, so the team used cells from the cow.
The U.S. Food and Drug Administration approved the cow-human transfusion method in 2011.
But in 2014, the FDA removed the cow’s immune system from the list of approved products and the technology is still banned in the U.K.
It wasn’t immediately clear how the cow antibodies were made, but the new technique uses an antibody made by a lab in China, according in a statement to ABC News.
The antibodies-which the researchers were able to make with a 3-D printer-are also used to make antibodies that could protect against a number of viruses, including herpes simplex, polio and anthrax.
They also have anti-rabbit antibodies that can be used against fleas and ticks.
“The new technique could also help prevent the spread of disease through the herd and reduce the need for animal-to, human transfusions,” the statement said.
The vaccine was approved by the FDA in 2010, but it has yet to be licensed.
It is unclear whether the new cow cells could be grown in humans, but there are animal-derived antibodies that have been used successfully for human transplant.
The antibodies are also being used for vaccines.
The UTMB’s team plans to make cow cells in the lab to produce human antibodies.
“We have some great opportunities in the human antibody research pipeline that we’re exploring,” Smith told ABC News, “but I don’t have any details about where we’ll go.”
The new technology is being developed in collaboration with the Texas-based National Institute of Allergy and Infectious Diseases, which has been working with the UT MB and the UT-Austin Medical School to develop human antibodies for vaccine development.